1. Home
  2. OGEN vs ICCT Comparison

OGEN vs ICCT Comparison

Compare OGEN & ICCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGEN
  • ICCT
  • Stock Information
  • Founded
  • OGEN 1996
  • ICCT 1992
  • Country
  • OGEN United States
  • ICCT United States
  • Employees
  • OGEN N/A
  • ICCT N/A
  • Industry
  • OGEN Biotechnology: Pharmaceutical Preparations
  • ICCT Computer Software: Prepackaged Software
  • Sector
  • OGEN Health Care
  • ICCT Technology
  • Exchange
  • OGEN Nasdaq
  • ICCT Nasdaq
  • Market Cap
  • OGEN 9.8M
  • ICCT 9.1M
  • IPO Year
  • OGEN N/A
  • ICCT N/A
  • Fundamental
  • Price
  • OGEN $1.12
  • ICCT $0.86
  • Analyst Decision
  • OGEN
  • ICCT
  • Analyst Count
  • OGEN 0
  • ICCT 0
  • Target Price
  • OGEN N/A
  • ICCT N/A
  • AVG Volume (30 Days)
  • OGEN 115.4K
  • ICCT 28.4K
  • Earning Date
  • OGEN 08-12-2024
  • ICCT 08-08-2024
  • Dividend Yield
  • OGEN N/A
  • ICCT N/A
  • EPS Growth
  • OGEN N/A
  • ICCT N/A
  • EPS
  • OGEN N/A
  • ICCT N/A
  • Revenue
  • OGEN $20,629.00
  • ICCT $9,034,579.00
  • Revenue This Year
  • OGEN N/A
  • ICCT N/A
  • Revenue Next Year
  • OGEN N/A
  • ICCT N/A
  • P/E Ratio
  • OGEN N/A
  • ICCT N/A
  • Revenue Growth
  • OGEN N/A
  • ICCT 16.06
  • 52 Week Low
  • OGEN $0.97
  • ICCT $0.81
  • 52 Week High
  • OGEN $7.74
  • ICCT $10.60
  • Technical
  • Relative Strength Index (RSI)
  • OGEN 38.96
  • ICCT 43.97
  • Support Level
  • OGEN $1.00
  • ICCT $0.81
  • Resistance Level
  • OGEN $1.24
  • ICCT $0.93
  • Average True Range (ATR)
  • OGEN 0.08
  • ICCT 0.06
  • MACD
  • OGEN 0.02
  • ICCT 0.00
  • Stochastic Oscillator
  • OGEN 27.36
  • ICCT 41.60

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.

About ICCT iCoreConnect Inc. Common stock

iCoreConnect Inc develops and markets secure cloud-based HIPAA compliant software services focused on compliance, workflow/productivity, and electronic health records systems. Its core services technology can be adopted to other vertical markets that require a high degree of secure data communication, such as the legal, financial, and education fields. It markets secure HIPAA compliant cloud-based software as a service (SaaS) offering under the names of iCoreExchange, iCoreCodeGenius, iCoreSecure, iCoreMD, iCoreDental, iCoreMobile, iCoreHuddle, iCoreRx, iCorePDMP, iCoreEPCS, and iCorePay. The company's software is sold under annual recurring revenue subscriptions. The company has a single reporting segment for reporting purposes focused on the North American market.

Share on Social Networks: